SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Phillip CS, Dilley A, Saidi P, Evatt BL, Austin H, Zawadsky J, Harwood D, Ellingsen D, Barnhart E, Phillips DJ, Hooper WC. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty. Thromb Haemost 1999; 80: 869873.
  • 2
    Dilley A, Austin H, Hooper WC, Lally C, Ribeiro MJA, Wenger NK, Silva V, Rawlins P, Evatt BL. Relation of three genetic traits to venous thrombosis in an African-American population. Am J Epidemiol 1998; 147: 3035.
  • 3
    Chabielska E, Pawlak R, Golatowki J. Losartan inhibits experimental venous thrombosis in spontaneously hypertensive rats. Thromb Res 1998; 90: 271278.
  • 4
    Erickson LA, Fici GJ, Lund JE, Boyle TP, Polites HG, Marotti KR. Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene. Nature 1990; 346: 7476.
  • 5
    Dzau VJ. Cell biology and genetics of angiotensin in cardiovascular disease. J Hypertens 1994; (Suppl): S3S10.
  • 6
    Berk BC, Vekshetein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989; 13: 305314.
  • 7
    Jonston CI. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair and remodeling. Hypertension 1994; 23: 258268.
  • 8
    Fishel RS, Eisenberg S, Shai S-Y, Redden RA, Bernstein KE, Berk BC. Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle. Hypertension 1995; 25: 343349.
  • 9
    Lindpaintner K, Lu W, Neidermajer N, et al. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J Mol Cell Cardiol 1993; 25: 133143.
  • 10
    Paxton WG, Runge M, Horaist C, Cohen C, Alexander RW, Bernstein KE. Immunohistochemical localization of rat angiotensin II AT1 receptor. Am J Physiol 1993; 264: F989F995.
  • 11
    Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, Horiuchi M, Pratt RE, Dzau VJ, MacMahon S. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995; 345: 16001603.
  • 12
    Cambien F, Costerousse O, Tiret L, Poirer O, Lecerf L, Gonzales MF, et al. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994; 90: 669676.
  • 13
    Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type I receptor gene polymorphism on risk of myocardial infarction. Lancet 1994; 344: 910913.
  • 14
    Villard E, Tiret L, Visvikis S, Rakotovao R, Cambien F, Soubrier F. Identification of new polymorphisms of the angiotensin I converting enzyme (ACE) gene and study of their relationship to plasma ACE levels by two-qtl segregation-linkage analysis. Am J Hum Genet 1996; 58: 12681278.
  • 15
    Paillard F, Chansel D, Brand E, Benetos A, Thomas F, Czekalski S, Ardaillou R, Soubrier F. Genotype–phenotype relationship for the renin–angiotensin–aldosterone system in a normal population. Hypertension 1999; 34: 423429.
  • 16
    Foy CA, Rice GI, Ossei-Gerning N, Mansfield MW, Grant MW. Angiotensin-converting enzyme (ACE) gene polymorphisms in patients characterised by coronary angiography. Hum Genet 1997; 100: 420425.
  • 17
    Schulman S, Wiman B, The Duration of Anticoagulation (DURAC) Trial Study Group. The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Thromb Haemost 1996; 75: 607611.
  • 18
    Gram J, Sidelmann J, Jespersen J. Does low protein concentrations of tissue-type plasminogen activator predict a low risk of spontaneous deep vein thrombosis. Thromb Haemost 1995; 74: 718721.
  • 19
    Vaughan DE. The renin–angiotensin system and fibrinolysis. Am J Cardiol 1997; 79 (5A); 1216.
  • 20
    Ridker PM, Gaboury CL, Conlin PR, Seely EW, Williams GH, Vaughan DE. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II: evidence of a potential interaction between the renin–angiotensin system and fibrinolytic function. Circulation 1993; 87: 19691973.
  • 21
    Martin DO, Austin H. Exact estimates for a rate ratio. An efficient program for computing conditional maximum likelihood estimates and exact confidence limits for a common odds ratio. Epidemiology 1991; 2: 359362.
  • 22
    Rothman KL, Greenland S. Modern epidemiology. 2nd edition. Philadelphia: Lippincott-Raven; 1998.
  • 23
    Rutledge DR, Browe CS, Kubilis PS, Ross EA. Analysis of two variants of the angiotensinogen gene in essential hypertensive African-Americans. Am J Hypertens 1994; 7: 651654.
  • 24
    Hooper WC, Dilley A, Riberio MJA, Benson J, Austin H, Silva V, Rawlins P, Wenger NK, Evatt BL. A racial difference in the prevalence of the Arg506[RIGHTWARDS ARROW]Gln mutation. Thromb Res 1996; 81: 577581.
  • 25
    Dilley A, Austin H, Hooper WC, El-Jamil M, Whitsett C, Wenger NK, Benson J, Evatt BL. Prevalence of the prothrombin 20210 G-to-A variant in blacks: infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects. J Lab Clin Med 1998; 132: 452455.
  • 26
    O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schafer EJ, Myers RH, Levy D. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham heart study. Circulation 1998; 97: 17661772.
  • 27
    Beohar N, Damaraju S, Prather A, Yu Q-T, Razier A, Kleiman NS, Roberts R, Marian AJ. Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. J Invest Med 1995; 45: 275280.
  • 28
    Schuster H, Weinker TF, Stremmler U, Noll B, Steinmetz A, Luft FC. An angiotensin-converting enzyme gene variant is associated with acute myocardial infarction in women but not in men. Am J Cardiol 1995; 76: 601603.
  • 29
    Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 11: 169180.
  • 30
    Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993; 4: 5961.
  • 31
    Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, Horiuchi M, Pratt RE, Dzau VJ, MacMahon S. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995; 345: 16001603.
  • 32
    Tiret L, Bonnardeux A, Poirer O, Ricard S, Marques-Vidal P, Evans A, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 gene polymorphisms on risk of myocardial infarction. Lancet 1994; 334: 910913.